NEIL NARDINI: Open Payments
NPI 1871879718 · PALMER, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 34 payments from 11 companies in 2025. Trend: 2023 $1,147 · 2024 $1,055 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $232 |
| AstraZeneca Pharmaceuticals LP | 10 | $201 |
| ABBVIE INC. | 7 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $89 |
| Lilly USA, LLC | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Digestive Care, Inc. | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| PFIZER INC. | 1 | $25 |
Products named: EVENITY, AIRSUPRA, VRAYLAR, CAPLYTA, FARXIGA, MOUNJARO, GEMTESA, UBRELVY.
Industry payments across AK — which companies pay providers there.
